Last Updated on October 7, 2024 by The Health Master

Drug alert

Drug alert: Download the list of NSQ samples for May 2024, the link is given below: 52 drug samples declared as not of standard quality (NSQ), nationwide.

NSQ Lists are given below the article

Out of these 52 samples, 39 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.

Out of these 13 samples were declared NSQ by various STATES across India, 5 were declared as Misbranded.

Details of the NSQ samples declared by STATES is as under:

Sr.	Name of STATES	Number of NSQ samples declared
1	Telangana	13
	Total	13

NOTE:

1. NSQ data was not received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Jharkhand, Jammu &
Kashmir (MD and ED not appropriate), Kerala (Expiry date not specified). for the Month of May, 2024 as per DCG(I) Circular dated
09.02.2024.

2. Sate Drugs Licensing Authorities of Goa have stated that the NSQ data as “NIL” for the Month of M ay, 2024.

3. State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Haryana, Himachal
Pradesh, Maharashtra, Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Rajasthan, Sikkim, Tamil Nadu, Uttarakhand, West
Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the
Not of Standard Quality (NSQ) Alert for the Month of May, 2024 as per DCG(I) Circular dated 09.02.2024.

Drug alert: Previous months

April 2024: Out of these 50 samples, 33 were declared NSQ by CDSCO and 17 were declared NSQ by various STATES across India.

During the month of March 2024, the authorities tested 931 samples, out of which 864 were of standard quality. The number of samples declared as not of standard quality was 66, with one being misbranded and none being spurious.

During the month of February 2024, the authorities tested 1167 samples, out of which 1018 were of standard quality. The number of samples declared as not of standard quality was 58, with none being misbranded and two being spurious.

During the month of January 2024, the authorities tested 932 samples, out of which 886 were of standard quality. The number of samples declared as not of standard quality was 46, with none being misbranded and none being spurious.

During the month of December 2023, the authorities tested 1008 samples, out of which 930 were of standard quality. The number of samples declared as not of standard quality was 78, with none being misbranded and none being spurious.

During the month of November 2023, the authorities tested 1197 samples, out of which 1133 were of standard quality. The number of samples declared as not of standard quality was 62, with one being misbranded and one being spurious.

During the month of October 2023, the authorities tested 1105 samples, out of which 1044 were of standard quality. The number of samples declared as not of standard quality was 61, with none being misbranded and none being spurious.

During the month of September 2023, the authorities tested 1188 samples, out of which 1126 were of standard quality. The number of samples declared as not of standard quality was 62, with none being misbranded and none being spurious.

During the month of August 2023, the authorities tested 1166 samples, out of which 1118 were of standard quality. The number of samples declared as not of standard quality was 48, with none being misbranded and none being spurious.

During the month of July 2023, the authorities tested 1306 samples, out of which 1252 were of standard quality. The number of samples declared as not of standard quality was 51, with none being misbranded and 3 being spurious.

During the month of June 2023, the authorities tested 1273 samples, out of which 1225 were of standard quality. The number of samples declared as not of standard quality was 48, with none being misbranded and one being spurious.

During the month of May 2023, the authorities tested 1302 samples, out of which 1274 were of standard quality. The number of samples declared as not of standard quality was 27, with none being misbranded and one being spurious.

The test samples were drawn by the zonal and sub-zonal offices of CDSCO, and tested in the drug testing laboratories, i.e CDLs, CDTLs, and RDTLs, in Kolkata, Mumbai, Hyderabad, Chandigarh, Indore, and Guwahati.

List of Drugs declared as NSQ by CDSCO for the Month of May– 2024.

A. CDSCO/Central Laboratories
S.No	Name of Drugs/medical device/cosmetics	Batch No.	Date of Manufactur e	Date of Expiry	Manufactured By	NSQ Result	Reported by CDSCO Laboratory
1.	Terbutaline Sulfate,Bromhexin e Hydrochloride with Guaiphenesin Syrup	VS16010	01-01-2024	01-12-2026	Priya Life Science,174-A, 175, Siddhi Industrial Infrastructure Park, Opp. Waghodia GIDC, Waghodia	The   sample   does    not conform to Manufacturer’s Specification with respect to the Assay of Bromhexine Hydrochloride and Terbutaline Sulphate.	Central Drugs Laboratory, Kolkata
2.	METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS IP	GT3J026	01-10-2023	30-09-2025	Scott-Edil Pharmacia Ltd.,56, EPIP., Phase-I, Jharmajri, Baddi, Distt. Solan-173          205, (H.P.), INDIA	The sample does not conforms to claim as per I.P.2022inrespectto the Test of Dissolution (1Hr), Dissolution (4 Hours)	Central Drugs Laboratory, Kolkata
3.	Cuftin COUGH LINCTUS	ECT- 2421	01-09-2023	31-08-2025	ELFOS LABORATORIES at : F-54, M.I. Area, JAIPUR- 17	The    sample    does          not conforms to claim  as per Patent and Proprietary in respect to the Assay of Sodium Citrate	RDTL, Chandigarh
4.	CefuroximeAxetil Tablets IP	DB23030 4	01-12-2023	30-11-2025	Daxin Pharmaceuticals Pvt. Ltd., PlotNo 121-122 EPIP, Jharmajri Phase 1, Teh.   Baddi, Distt. Solan (H.P.) – 174103	The sample does not conforms to claim as per IP 2022in respect to the Test of Dissolution of Cefuroxime Axetil equivalent to Cefuroxime	Central Drugs Laboratory, Kolkata
5.	LevosalbutamolSul phate,AmbroxolHC L,Guaiphenesin Syrup	5346	07-03-2024	04-02-2026	Esquire Drug House,138, GIDC, Estate, Wadhwan City, District	The   sample    does    not conform to claim as per Schedule V of Drugs & Cosmetics Act with respect	Central Drugs Laboratory, Kolkata
					Surendranagar                             363035 (Gujarat)	To Assay  of Levosalbutamol Sulphate Equivalent to Levosalbutamol. NB:The sample does not give positive test for Diethylene glycol and is found to contain 0.0071 % w/v Ethylene glycol; (Limit NMT 0.1% w/v, Method: GC, Ref: USP under the monograph of Propylene glycol,)
6.	Acetylsalicylic Acid Tablets 75 mg	JTN23- 211	05-07-2023	03-06-2026	AK Krishna Pharma Pvt.Ltd., Plot No. 68, 69 &82,83, Sector-6A, Sidcul, IIE, Dist. Haridwar, Uttarakhand, India.	Sample does not conforms to IP with respect to test for Dissolution.	Central Drugs Laboratory, Kolkata
7.	LactuloseSolution U.S.P.	GA2312 7	02-11-2023	07-10-2025	Skymap Pharmaceuticals Pvt.       Ltd., B-3,              Dev Bhoomi Industrial Estate, PuhanaIqbalpur      Road, Roorkee-247667	The   sample   does    not conforms to claim as per U.S.P.in respect to the Assay.	Central Drugs Laboratory, Kolkata
8.	Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesinand Menthol Syrup	23D-20	01-04-2023	31-03-2025	RADICALS PHARMA PVT. LTD.,194, Mile Stone, Ambala-Delhi Highway Shahpur, Ambala Cantt- 133004 (Hry.)	The sample does not conforms to claim as per Patent and Proprietary (RDTL/MS/3286) in respect to the Assay of Terbutaline                            Sulphate, Bromhexine Hydrochloride	RDTL, Chandigarh
9.	Prednisolone TabletsIP10mg	PRDT- 1007	01-11-2022	31-10-2024	WINGSBIOTECH LLP,43 & 44, HPSIDC, Industrial Area, Baddi – 173205 (H.P.)	The sample does not conforms to claim as per IP 2018 and Addendum 2021 in respect to the Assay of Prednisolone	RDTL, Chandigarh
10.	Mecobalamin, AlphaLipoicAcid, Pyridoxine Hydrochlorideand Folic Acid Soft Gelatin Capsules	DBIS- 8591	02-11-2023	08-10-2025	Broad Injectables,PlotNo. 51-52, Ind. Area TahliwalDistt.                              Una 174301 (H.P.)	The sample does not conforms to claim as per Schedule V of Drugs and Cosmetics Act with respect to the Assay/content of Mecobalamin                                      and PyridoxineHydrochloride	Central Drugs Laboratory, Kolkata

11.	TELMISARTAN ANDAMLODIPINE TABLETS IP	TE3016A	01-05-2023	30-04-2025	M/s. NavkarLifesciences,Plot No.      76,           LodhiMajra, Industrial   Area,           Baddi, Distt. Solan (H.P.)	The      sample      received DOES   NOT   CONFORM toI.P.2022Specification with respect to the test parameters                    Dissolution and Assay of  Amlodipine Besylate     equivalent                   to Amlodipinecontentonly. CDTLHREPORTNO.: CDTLH/1510/F- 1068/2023-24	CDTL, Hyderabad
12.	Cefoperazone& Sulbactam for Injection	B- 22680D	01-01-2023	02-12-2024	Pace Biotech, Surajpur, Paonta Sahib, Dist- Sirmour (H.P)- 173001	The sample does not conforms to claim as per The Schedule V of The Drugs and Cosmetics Act,1940withrespectto the Test for ‘Clarity of solution’ and’ Particulate matter’	Central Drugs Laboratory, Kolkata
13.	Cefotaxime InjectionIP500mg	CTI2308 1	08-08-2023	07-01-2025	M/s. Vivek Pharmachem (India) Ltd., NH-8, Chimanpura, Amer, Jaipur-303 102 INDIA	The sample does not conforms to I.P. with respect to the Test for ‘Related Substances’, ‘Particulate matter’ and ‘Clarity of solution’	Central Drugs Laboratory, Kolkata
14.	Dexamethasone SodiumPhosphate Injection I.P	DSA123 13	06-07-2023	04-06-2025	M/s   Nandani    Medical Laboratories                                   Pvt. Ltd.,,221/5,Bicholi Hapsi, Kanadia Road, Indore	The    sample    does     not conforms to IP with respect to         Assay/        content    of Dexamethasone Phosphate	Central Drugs Laboratory, Kolkata
15.	Amoxycillin&Potas sium Clavulanate InjectionIP1.2gm	23AP04	03-05-2023	02-04-2025	SAI Parenterals Limited, D1&D4, Survey No.280,Phase-V,                                  IDA, Jeedimetla,                      Hyderabad, 500055, TS	The   sample    does    not conforms to claim as per I.P. 2022 in respect to the Test of Clarity of solution and Assay of Potassium Clavulanate calculated as Clavulanic Acid	Central Drugs Laboratory, Kolkata
16.	TELMISARTAN AND METOPROLOL SUCCINATE (EXTENDED RELEASE) TABLETS	BD23178 0H	01-12-2023	30-11-2025	BIOALTUS PHARMACEUTICA LS PRIVATE LIMITED, (A WHO GMP CERTIFIED COMPANY) At: 19- 20, DIC, Ind. Area, Baddi, Distt. Solan, (H.P.) 173205	NOTE:     THE     SAMPLE RECEIVED    DOES            NOT CONFORM                                  TO MANUFACTURERS SPECIFICATION               WITH RESPECT TO THE TEST FOR DISSOLUTION FOR THE              CONTENT              OF METOPROLOL SUCCINATE EQUIVALENT TO METOPROLOL TARTRATE (EXTENDED RELEASE) AT THE FINAL TEST TIME (20th HOUR) OF     L1+L2+L3          LEVEL ONLY. CDTLHREPORTNO.: CDTLH/1527/F-	CDTL, Hyderabad
17.	Pantoprazole Tablets I.P..	PAA-507	01-06-2023	31-05-2025	Healers Lab, Unit II, Plot No.    33, HPSIDC, Extn., Baddi, Distt.Solan, (H.P.)	The    sample    Does    not complies        conforms to  Manufacturer Specification with respect to the above tests only.	RDTL, Guwahati
18.	Pantoprazole Tablets I.P..	PAA-507	01-06-2023	31-05-2025	Healers Lab, Unit II,Plot No.     33,          H.P.S.I.D.C., Extn., Baddi,Distt.Solan (H.P.)	The sample Does not complies conforms to Manufacturer Specification with respect to the above tests only.	RDTL, Guwahati
19.	Ambroxol HCl, Levosalbutamoland Guaiphenesin Syrup	VDL- 1240	01-07-2022	30-06-2024	VVPB Pharmaceuticals Pvt. Ltd., Kh.  No. 114, Vill. Damowala, P.O. Barotiwala, Baddi, Distt. Solan (H.P.)	The   sample    does    not conforms to claim as per Patent and Proprietary in respect to the Test of Diethylene Glycol (DEG) and Assay   of Ambroxol Hydrochloride	RDTL, Chandigarh
20.	Dexamethasone Sodium Phosphate Injection I.P. (8mg/2ml)	323-885	03-08-2023	09-07-2025	ZEE    LABORATORIES LTD., Behind 47, Industrial Area, Paonta Sahib- 173025	The    sample     does           not conforms to IP with respect to test for           “Free Dexamethasone”, “Particulate                  matter,”, “Extractable           volume” ,”Assay                             of Dexamethasone                               Sodium Phosphate calculated as Dexamethasone Phosphate” and is also not of standard quality for the reason stated under “Description”.	Central Drugs Laboratory, Kolkata

21.	Dexamethasone Sodiumphosphate Injection IP	DX-2305	05-05-2023	04-04-2025	M/s. Konis Pharmaceuticals, Krishna Nagar – 522502 (A.P.)	The sample does not conforms to claim as per IP2022 in respect to the Test of Description and Particulate matter	Central Drugs Laboratory, Kolkata
22.	Paracetamol 500 mg. Tablets	PAR-31	01-08-2023	31-07-2026	ASKON HEALTH CARE,11-B, INDUSTRIAL AREA, MAXI ROAD, UJJAIN- 456010 (M.P.)	The    sample    Does          not Complies          conforms to I.P. with respect to   the above tests only.	RDTL, Guwahati
23.	Ofloxacin Ornidazole Tablets IP	AD24059	01-04-2024	31-03-2026	Skymap Pharmaceuticals Pvt.       Ltd., (A             WHO- GMP Certified Company) B-3, Dev Bhoomi Industrial Estate,  PuhanaIqbalpur                              Road, Roorkee-247667	Note: the sample received does                                    not conformtoi.p.2022 specification with respect to the test for dissolution for the content of ofloxacin and ornidazole ( s1, s2 and s3 level) only. Cdtlh report no.: cdtlh/0131/f –	CDTL, Hyderabad
24.	Vildagliptinand Metformin Hydrochloride Tablets IP 50mg/1000mg	VMC04G 23A	01-10-2023	30-09-2025	Bajaj Healthcare Ltd., R.S. No.1818, Manjusar – Savli Road, At & Post- Manjusar, Tal. Savli, Dist. Vadodara- 391775.	The   sample   does    not conform to IP with respect to the test for Dissolution and Assay of Vildagliptin.	Central Drugs Laboratory, Kolkata
25.	Amoxycillin & Potassium Clavulanate Tablets I.P..	TCV- 2303003	01-03-2023	28-02-2025	Rivpra Formulation Pvt. Ltd.,Plot No.8, Sector-6A,       I.I.E. SIDCUL, Haridwar- 249403, (U.K.)	The sample does not conform to I.P. with respect to the test for Assay.	RDTL, Guwahati
26.	Clonazepam TabletsI.P.0.5mg	04L23T0 3	06-12-2023	04-11-2026	M/s. Shine Pharmaceuticals Limited, PlotNo.               132,  Karjan- Vermardi Road,    Juni Jitherdi,                  Ta. Karjan-391240, Distt. Vadodara, (Gujarat).	The    sample    does          not conforms to claim as per IP in respect to The     Test     of           Related Substances	Central Drugs Laboratory, Kolkata
27.	Metronidazole Extended Release Tablets USP 600 MG	TC- 060323	03-03-2023	04-02-2025	Technica Lab & Pharma Pvt. Limited,            Plot          No. 100,     Sector-     7,            IIE, SIDCUL, Haridwar, Uttarakhand	The    sample    does          not conform   to U.S.P with respect   to                      the   test                 of Dissolution.	Central Drugs Laboratory, Kolkata
28.	Diclofenac Sodium and Paracetamol Tablets IP	RCT230 50	09-06-2023	04-02-2026	Galpha       Laboratories Limited..,Village – Thana, Baddi, Himachal Pradesh- 173 205.	The   sample   does    not conforms to claim as per IP in respect to the Test of Description	Central Drugs Laboratory, Kolkata
29.	Atropine Sulphate Injection IP	23UG18	01-07-2023	30-062025	SVP                                  LIFE SCIENCES, C/10-1 Sara    Industrial Estate, Selaqui, Dehradun	The   sample    does    not conforms to claim as per IP2022in respect to the Test of pH and Assay of Atropine Sulphate	RDTL , Chandigarh
30.	Montelukast Sodium & Levocetirizine Hydrochloride Tablets	ATA-176	01-02-2023	31-01-2025	Alliaance Biotech, 440/3, Village     Katha,                Baddi, Distt.Solan (HP) – 173205	The    sample     does          not conform to I.P. with respect to the above tests only.	RDTL, Guwahati

31.	Fluconazole Tablets IP (150 mg)..	UGT233 38	01-03-2023	28-02-2025	Unimark Healthcare Ltd., Plot No.: 24, 25 & 37 Sector 6 A, SIDCUL, Haridwar – 249403 (Uttarakhand)	The sample received does not conform to the I.P.2022 standard with respect to the test for Related substances.	CDTL, Mumbai
32.	Ceftriaxone Injection I.P	324-166	02-02-2024	07-07-2026	Zee                     Laboratories Limited, Behind47, Industrial Area, Paonta Sahib- 173205.	The   sample   does    not complies to claim as per IP 2022in respect of test for appearance of solution, clarity of solution, particulate matter and sterility (Powder for Injection).	Central Drugs Laboratory, Kolkata
33.	Ramipril & Hydrochlorthiazide Tablets IP	PT- 31954	01-07-2023	01-06-2025	Pharmaroots Healthcare, Khasra No. 411, Village Tipra, P.O. Barotiwala, Tehsil Baddi, Distt. Solan, H.P.	The sample received does not           conform      to           the I.P.2022standardwith respect   to   the   test   for assay of          Ramipril. Note:-Other test could not be done due to technical reason	CDTL, Mumbai
34.	GLIPIZIDEAND METFORMIN TABLETS IP	4010026	08-11-2023	03-04-2025	USV Private Limited, At : B-       249/B-250,          IInd Stage, Peenya Industrial Estate,                 Bangalore-560 058	The   sample   does    not conform to claim I.P. with respect to the test for Dissolution of Glipizide	CDL, Kolkata
35.	Ceftriaxone for InjectionI.P.1gm	DC3011 9	05-10-2023	09-09-2025	Captab Biotec, Unit- II, Plot No.125, E.P.I.P., Road, Mauja, Jharmajri, Baddi, Distt. Solan, H.P.	The   sample   does    not conforms to I.P. with respect to test for “Particulate Matter	CDL, Kolkata
36.	Gentamicin Sulphate Injection I.P. 2ml	323-216	03-03-2023	05-02-2025	ZEE    LABORATORIES LTD., Behind 47, Indl. Area, Paonta Sahib- 173025	The sample does not conforms to I.P. with respect to the test for “Particulate matter” and is also not of standard quality for the reason stated under “Description”	CDL, Kolkata
37.	Calcium 500 mg withVitaminD3250 IU Tablets IP	LMT240 263	01-03-2023	28-02-2026	Life       Max        Cancer Laboratories, Plot No. 106 & 106 A, Sector-6A, IIE, SIDCUL, Haridwar- 249403 (U.K)	The    sample    Does          not Complies     conforms                    to I.P. with respect to the above tests only.	RDTL, Guwahati
38.	Cefixime & Ofloxacin Tablets	DB23005 7	02-02-2023	01-01-2025	Daxin Pharmaceuticals Pvt.Ltd., Plot No 121-122 EPIP, Jharmajri Phase1, Teh. Baddi, Distt. Solan (H.P.) -174103	The sample does not conforms to claim as per Schedule V of Drugs & Cosmetics Act with respect to the Assay of Cefixime Trihydrate eq. to anhydrous          Cefixime and Assay of Ofloxacin	CDL, Kolkata
39.	Ceftriaxone Injection IP	C2402- 02F	02-02-2024	05-01-2026	Integrated                     Laboratories Pvt. Ltd., Nahan Road, Vill. Moginand, Kala Amb, Distt.       Sirmour               (H.P.)- 173030	The    sample    does          not conform to IP with respect to the Particulate matter, Clarity of Solution and for the reason stated under Description	Central Drugs Laboratory, Kolkata

List of Drugs declared as NSQ by STATES for the Month of May– 2024.

B. STATE LABORATORIES
S. No	Name of Drugs/medical device/cosmeti cs	Batch No.	Date of Manufactur e	Date of Expiry	Manufactured By	NSQ Result	Reported by CDSCO Laboratory
1.	Cyra Tablets, Rabeprazole Sodium Tablets IP	CA21868	07/2023.	06/2025.	Mfg By: Mepro Pharmaceuticals Pvt.Ltd, Unit-II, Q Road, Phase – IV, G.I.D.C. Wadhwan – 363035, Dist. Surendranagar, Gujrat.	NOT        OF                STANDARD QUALITY The     tablets      does            not complies in buffer stage for the              dissolution              test parameter, hence it is NOT OF STANDARD QUALITY.	State Lab Drugs Control Laboratory, Telangana.
2.	Rabedin tablet Tablets, Rabeprazole Sodium Gastro- Resistant Tabelts IP,	LV23HT- 034B	08/2023.	01/2025.	Mfg By: LV life Sciences VPO Gurumajra, BaddiDistt. Solan(H.P)- 174101. Himachal Pradesh. Mrkt: Odin Healthcare Pvt.Ltd, Plot No. 1, Industrial Area, ChambaghatSolan, H.P. – 173 213.	NOT OF STANDARD QUALITY The sample does not meet the acid stage acceptance criteria as per IP specifications, hence it is declared as NOT OF STANDARD QUALITY.	State Lab Drugs Control Laboratory, Telangana.
3.	Moxtas Distab 250 Tablets, Amoxycillin trihydrate dispersible tablets IP.	MALT- 2019	10/2023.	09/2025.	Mfg By: Wings Novitas Healthcare LLP 43 & 44, HPSIDC, Industrial area, Baddi – 173 205. (H.P). Himachal Pradesh.	NOT OF STANDARD QUALITY Tablets are with uneven surface and are crumbling while taking out of the strip. Hence failed with respect to the test Description of Tablets.	State Lab Drugs Control Laboratory, Telangana.
4.	Tolcenta-P Tablets,	ZT22806	12/2022.	11/2024.	Mfg By: Zenomed Health Care Pvt.Ltd. (ISO &	NOT OF STANDARD QUALITY	State Lab Drugs Control
	Tolperisone Hydrochloride and Paracetamol tablets,				GMP) Certificed NO. 70- 73, First Cross, Rainbow Nagar, Vazthuthavuran Pattai, Navamlkapper, Villupuram (Dt), Tamil Nadu – 605102 Tamil nadu. Mrkt: Elinova Pharma Pvt.Ltd, D.No. 5-74/301, Panchavati Colony, Hyderabad, Telangana.	While Opening the strip, the tablets are sticky in nature and adhering to the foil, hence the sample does not complies with respect to description. The assay content of Tolperisone Hydrochloride is not within the prescribed limit, hence the sample does not complies as per manufacturing method of analysis.	Laboratory, Telangana.
5.	Nagris Pakeezah Art Henna (3 Henna Cones)	–	Nil	Nil	Mfg By: Nagris Herbs, LN Nagar, Jiyaguda, Hyderabad.	NOT OF STANDARD QUALITY The sample does not conform to the test for determination of absence of Picramic Acid as per BIS standard IS 17318:2020 as required as per rule 39 (Standard of Cosmetics) 2020.As the cautions do not use for coluring eyelashes or eyebrows. Do not use on cut, Irritated or abranded skin as per Bis Standard IS 17318: 2020 is not mentioned on the label of the cosmetic sample. Hence, the sample not labeled in the prescribed manner and deemed to be Misbranded Cosmetics as	State Lab Drugs Control Laboratory, Telangana.
						per Section 17Cof Drugs and Cosmetics ACT, 1940.
6.	Oxifer-XT Tablets, Ferrous ascorbate elemental iron, Folic acid & Zinc sulphate Tablets,	EOX 2306	12/2023.	05/2025.	Mfg By: Eminent Remedies Plot No. 9/1/A, Road, NO.14 Near Telangana Foods IDA, Nacharam, Hyderabad – 500076 (TS), Telangana. Mrkt: Organic Pharma, H.No. 7-67/G3, Hyderabad.	NOT OF STANDARD QUALITY Sample does not meets the Specifications wrt Assay of elemental Iron (Ferrous Ascorbate).	State Lab Drugs Control Laboratory, Telangana.
7.	Levolets- M Kid Syrups, Montelukast Sodium & Levocetrizine Dihydrochloride syrup	RC24BL- 521	02/2024.	01/2026.	Mfg By: Rikencare Life sciences villmessaTibba, Pharmaceuticals O Manjholi, Tehsil- Nalagarh, DistSolan, HP- 174101 Himachal Pradesh. Mrkt: Manvi Life Sciences, 1-1-289, Ashoknagar, Hyderabad – 500020.	NOT OF STANDARD QUALITY Sample does not comply Description of syrup and Assay of Montelukast.	State Lab Drugs Control Laboratory, Telangana.
8.	Meazon Plus injection Parentaral Preparations, Mecobalamine, Folic acid & Niacianamideinj 1 ml,	23MP07	10/2023.	09/2025.	Mfg By: Sai parentrals limited D1&D4, Survey No. 280, Phase-V Hyderabad – 500 055 Telangana.	NOT OF STANDARD QUALITY Sample does not comply Assay of Folic Acid.	State Lab Drugs Control Laboratory, Telangana.
9.	XERONAC-SP Tablets, Aceclofenac, Paracetamol &	RP- T243/C	12/2023.	11/2025.	Mfg By: Roma Pharma Pvt.Ltd, Unit-II, Village Nagali, P.O. Barog, Tehsil &Distt. Solan, (H.P) – 173 211,	MISBRANDED The label of the drug does not indicate the comon name of the colur used as requied as per Rule 127(2)	State Lab Drugs Control Laboratory, Telangana.
	Serratiopeptidas e Tablets				Himachal Pradesh. Mrkt: Fornax Pharmaceuticals, No. 6- Anew no. 17, 2nd Floor, VOC Colony, 3rd Street, Amijikrai, Chennai – 600029. TN.	of Drugs Rules, 1945. Label only bears the words Approved colured used. Hence the drug is not labelled in the prescribed manner and is deemed to be Misbranded drug as per section 17(c) of the Drugs and Cosmetics Act 1940.
10	Pedxim-200 Tablets, Cefpodoximepro xetil Tablets 200 mg,	TBL- 2676	04/2023.	03/2025.	Mfg By: Ticomapharmaciae-17 Focal Pont, Derabassi- 140507, Distt. Mohali (Punjab) Punjab.	MISBRANDED The product name (title) indicated on the label is as CefpodoximeProxetil Tablets 200 mg instead of CefpodoximeProxetil Dispersible Tablets 200 mg. The label of the product does not state that the tablets should be dispersed in water immediately before use. Hence the product is not labeled in the prescribed manner and is deemed to be Misbranded drug as per section 17(c) of Drugs and Cosmetics Act.	State Lab Drugs Control Laboratory, Telangana.
11	DofloxOZT Tablets, Ofloxacin&Ornid azole Tablets	DDX230 1	06/2023.	05/2026.	MfgBy: Doctor’s Vet- Pharma Pvt.Ltd, P.R. Palem (V), Kovur(M), SPSR Nellore Dist. Andhra Pradesh. Mrkt: Doctor’s Life Sciences (India) Ltd, Survey NO. 263/1, 264/1, P.R. Palem (V),	MISBRANDED The drug product Ofloxacin and Ornidazole Tablets is official in Indian Pharmacopoeia. But the letters IP is not mentioned on the strip after the product name Ofloxacin and Ornidazole Tablets.	State Lab Drugs Control Laboratory, Telangana.
					Kovur (M), SPSR Nellore Dist – 524 137, A.P. India.	Hence it is Misbranded Drugs under Section 17(c) of drugs and cosmetics act.
12	Disinfectants, Surgical Spirit BP	SS- 053011	05/2023.	04/2025.	Mfg By: Transflexjawaharnagar, Raipur, (C.G)- 492001, Chhattisgarh.	MISBRANDED As per rule R.124 the drug is included in the current edition of Indian Pharmacopoiea 2022. Hence standards shall be of those as specified in Indian Pharmacopoiea 2022. But the subject drug Surgical spirit bears the letters B.P after the drug name instead of IP. As per rule 96 and 104 as the drug shall be in accordance with standards set out in Indian Pharmaopoiea, the name of the drug surgical spirit shall be followed by the letters IP. As the subject drug is not confirming to the said labelling requirements the drug shall be deemed to be Misbranded as per section 17.	State Lab Drugs Control Laboratory, Telangana.
13	Sif Alben Suspension, Albendazole Oral Suspension 2.5% w/v (Vet)	AL80012 3	05/2023.	04/2025.	Mfg By: Siflon Drugs & Pharmaceuticals Pvt.Ltd., Plot no. 20&21, Aleap IE, Gajularamaram (V), Hyderabad – 55 Telanga.	MISBRANDED The given sample Albendazole oral suspension is official included in the IP and required as per schedule of the Drugs and Cosmetics	State Lab Drugs Control Laboratory, Telangana.
						Act 1940. The given sample shall comply with the standards set out in IP but, the designation IP is conjunction with the official tittle Albendazoleoral suspension on label of the drug product was not mentioned as indication that the drug product purports to comply with IP standards. Hence the Drug product shall be deemed to be Misbranded drug as per section 17 of Drugs and Cosmetics Act.

---

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• Fire explosion at Aurore Pharmaceuticals
  November 21, 2024
• Drug recall: Cipla recalls over 1.8k boxes of this drug
  November 21, 2024
• USFDA issued Form 483 with 7 observations to Dr Reddy’s
  November 20, 2024
• NPPA Revises Ceiling Prices of these Key Drugs
  November 20, 2024
• Approval of Anti Cancer drug Nivolumab for new Indication
  November 19, 2024
• Trump 2.0 Agenda: A Boon for Indian Pharma Industry?
  November 19, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: